In August 2012, Johnson & Johnson agreed to pay $181 million to 36 states and the District of Columbia to settle fraud charges related to its unlawful marketing of Risperdal. In January 2012, Johnson & Johnson agreed to pay $158 million to settle a lawsuit filed by the State of Texas alleging that J&J illegally marketed Risperdal to state residents on Medicaid.Īfter the settlement, Texas attorney general Greg Abbott stated: “Johnson & Johnson’s scheme to profit from the Medicaid program by overstating the safety and effectiveness of an expensive drug and improperly influencing officials ended up costing taxpayers millions of dollars.” 36 States v. Here is a brief history of Risperdal settlements. With thousands of these cases yet to go to trial, and the memory of these massive awards fresh in their minds, experts expect J&J will reach settlements in most Risperdal lawsuits to save themselves time and money. Yount about taking Risperdal but had destroyed evidence related to the case. The jury ruled that J&J had not only failed to warn Mr. The awards in these cases totaled nearly $5 million, with Austin Pledger alone receiving $2.5 million (see below: “Pledger”).īut even those awards pale in comparison to Andrew Yount, who was awarded $70 million by a Philadelphia jury in July 2016. In 2016 J&J lost three individual Risperdal lawsuits that went to trial. The most recent confidential settlement occurred on November 2, 2016. From 2012 to 2013, drug maker Johnson & Johnson settled more than 80 such cases for undisclosed amounts. There is a strong precedent for settlement in Risperdal lawsuits.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |